COVID-19 infection raises respiratory type 2 inflammatory disease risk, whereas vaccination is protective
COVID-19 infection is associated with a heightened risk of respiratory type 2 inflammatory diseases, whereas vaccination appears protective.
Authors
- Gema Hernandez
- Ralf Joachim Ludwig (ORCID: https://orcid.org/0000-0002-1394-1737)
- Philip Curman (ORCID: https://orcid.org/0000-0003-2051-8491)
- Khalaf Kridin (ORCID: https://orcid.org/0000-0001-9971-9151)
- Henning Olbrich (ORCID: https://orcid.org/0000-0003-0863-7148)
- Diamant Thaçi (ORCID: https://orcid.org/0000-0001-8513-550X)
- Sophie L Preuß (ORCID: https://orcid.org/0000-0003-0661-7573)
Institutions
- Karolinska University Hospital (SE)
- Karolinska Institutet (SE)
- University Hospital Schleswig-Holstein (DE)
- Universidad Politécnica de Madrid (ES)
- University of Lübeck (DE)
Publication Details
- Journal
- Journal of Allergy and Clinical Immunology
- Published
- 2025-08-12
- DOI
- https://doi.org/10.1016/j.jaci.2025.07.030
- Citations
- 1
- Primary Topic
- Asthma and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 1.16
Funders
- Deutsche Forschungsgemeinschaft
- Stockholms Läns Landsting